v3.26.1
Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance $ 5,615,288  
Ending balance 48,032,895 $ 5,615,288
Recurring [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 5,615,288 84,591
Change in fair value of derivative liabilities (2,732,106) $ (202,959)
Exercise (in Shares)   (4,099)
Derivative Liabilities Recognized at Grant Date 45,149,713 $ 5,737,755
Ending balance 48,032,895 5,615,288
Recurring [Member] | August 2020 [Member] | Underwritten Public Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 21
Change in fair value of derivative liabilities $ (21)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date
Ending balance
Recurring [Member] | February 2021 [Member] | Registered Direct Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 219
Change in fair value of derivative liabilities $ (219)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date
Ending balance
Recurring [Member] | May 2021 [Member] | Registered Direct Offering Investors Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 12,823
Change in fair value of derivative liabilities $ (12,823)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date
Ending balance
Recurring [Member] | May 2021 [Member] | Registered Direct Offering Placement Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 962
Change in fair value of derivative liabilities $ (962)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date
Ending balance
Recurring [Member] | November 2021 [Member] | Private Placement Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 64,586
Change in fair value of derivative liabilities $ (60,487)
Exercise (in Shares)   (4,099)
Derivative Liabilities Recognized at Grant Date
Ending balance
Recurring [Member] | November 2021 [Member] | Private Placement Placement Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 5,980
Change in fair value of derivative liabilities $ (5,980)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date
Ending balance
Recurring [Member] | November 2025 [Member] | Private Placement Investors Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 4,493,099
Change in fair value of derivative liabilities 440,056 $ (231,066)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date $ 4,724,165
Ending balance 4,933,155 4,493,099
Recurring [Member] | November 2025 [Member] | Registered Direct Offering Pre-funded Warrant [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 1,122,189
Change in fair value of derivative liabilities 81,448 $ 108,599
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date $ 1,013,590
Ending balance 1,203,637 1,122,189
Recurring [Member] | June 2026 [Member] | Units Private Placement Investors Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance
Change in fair value of derivative liabilities (3,253,610)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date 45,149,713
Ending balance $ 41,896,103